HelloGard Welcomes Sarah Hoit to Advisory Board   •   LOUISIANA'S ACADIANA PLANNING COMMISSION HONORED FOR REDUCING SEVERE CRASHES AT RURAL "T" INTERSECTIONS   •   University of Phoenix publishes Annual Academic Report for FY2022 detailing dynamic innovations and noteworthy achievements   •   The ODP Corporation to Present at the Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference Monday, D   •   SBB Research Group Foundation Names September 2023 Grant Finalists: In His Hands Resource Center, Milton Township Food Pantry, P   •   Groundswell Fund Announces Yamani Yansá Hernandez as Its Next CEO   •   University of Hamburg Awarded the 2023 WRDS-SSRN Innovation Prize for Commitment to Academic Research   •   MINNESOTA DEPARTMENT OF TRANSPORTATION HONORED FOR WIDESPREAD USE OF "J-TURN INTERSECTIONS" TO REDUCE SEVERITY OF CRASHES   •   FLORIDA DEPARTMENT OF TRANSPORTATION HONORED FOR FRICTION TREATMENT THAT REDUCES STOPPING DISTANCES AT INTERSECTIONS   •   TEXAS DEPARTMENT OF TRANSPORTATION HONORED FOR REDUCING PEDESTRIAN FATALITIES ON AUSTIN'S I-35   •   Impact Podcast with John Shegerian to Feature Lineup of “ESG All-Stars” from Iconic Brands for December   •   Port Houston Second Annual Posada   •   Zeta Marketing Platform Surges With 64% YoY Increase in Omnichannel Marketing During Holiday Season Kickoff   •   SOUTH JERSEY TRANSPORTATION PLANNING ORGANIZATION HONORED FOR CUMBERLAND COUNTY PLAN TO PROTECT PEDESTRIANS AND CYCLISTS   •   Ecolomondo Releases Its Interim Consolidated Financial Statements for the Third Quarter of 2023. Provides Amendment to Market Ma   •   Sila Begins the Build-Out of its Moses Lake Plant for 2025 Production of Titan Silicon   •   Oceaneering Announces Release of 2023 Task Force on Climate-Related Financial Disclosures Report   •   CALTRANS HONORED FOR ENHANCING PEDESTRIAN SAFETY AND PREVENTING WRONG-WAY DRIVING AND RUN-OFF-ROAD CRASHES   •   QBE North America Employees Take Over 17 Million Steps to Raise More Than $50K for Cerebral Palsy Research   •   Astellas' Fezolinetant Reduces Frequency and Severity of VMS Associated with Menopause in Women Considered Unsuitable for Hormon